BIK and breast carcinoma: Restoration of BIK expression by removal of epigenetic markers via inhibition of these lncRNAs or by DNA methyltransferases (DNMTs) / Histone methyltransferases (HMTs) inhibitors could therefore represent a potential therapeutic strategy for treatment of refractory breast cancer.